Standout Papers
- Lebrikizumab Treatment in Adults with Asthma (2011)
- An Official American Thoracic Society Public Policy Statement: Novel Risk Factors and the Global Burden of Chronic Obstructive Pulmonary Disease (2010)
- Pulmonary Dead-Space Fraction as a Risk Factor for Death in the Acute Respiratory Distress Syndrome (2002)
- Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury* (2005)
- Omalizumab in Severe Allergic Asthma Inadequately Controlled With Standard Therapy (2011)
- Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials (2016)
Immediate Impact
1 from Science/Nature 118 standout
Citing Papers
Chronic obstructive pulmonary disease
2022 Standout
Acute respiratory distress syndrome in adults: diagnosis, outcomes, long-term sequelae, and management
2022 Standout
Works of Mark D. Eisner being referenced
Recent trends in acute lung injury mortality: 1996–2005*
2009
Randomized Clinical Trial of Activated Protein C for the Treatment of Acute Lung Injury
2008
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Mark D. Eisner | 8342 | 5281 | 1804 | 1951 | 168 | 13.8k | |
| A. Sonia Buist | 17934 | 11155 | 1718 | 1685 | 205 | 23.9k | |
| Pierre Ernst | 7562 | 6966 | 592 | 1020 | 213 | 12.5k | |
| Kevin B. Weiss | 5336 | 6000 | 938 | 1467 | 221 | 13.5k | |
| Louis‐Philippe Boulet | 9006 | 11726 | 959 | 564 | 355 | 16.1k | |
| Jerry A. Krishnan | 5717 | 3845 | 467 | 987 | 214 | 9.9k | |
| Ulrich Keil | 3053 | 5504 | 1629 | 1322 | 171 | 14.1k | |
| John E. Connett | 7357 | 5996 | 604 | 1291 | 234 | 14.6k | |
| Sanja Stanojevic | 11561 | 4973 | 830 | 1307 | 187 | 14.7k | |
| Bo Lundbäck | 7190 | 7751 | 1641 | 541 | 253 | 12.0k | |
| Amund Gulsvik | 7578 | 4928 | 951 | 588 | 203 | 10.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...